SpringWorks Therapeutics ...

NASDAQ: SWTX · Real-Time Price · USD
46.99
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM

SpringWorks Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
69.75M 176.05M 67.49M 103.96M
Short-Term Investments
238.23M 303.15M 524.72M 269.54M
Long-Term Investments
158.12M 185.34M 8.99M 62.11M
Other Long-Term Assets
6.47M 4.25M 3.23M 3.27M
Receivables
46.24M 5.93M n/a n/a
Inventory
10.21M 3.1M n/a n/a
Other Current Assets
16.03M 12.68M 7.55M 9.41M
Total Current Assets
380.46M 500.91M 599.76M 382.91M
Property-Plant & Equipment
26.66M 24.09M 18.27M 4.2M
Goodwill & Intangibles
15.56M 11.2M n/a n/a
Total Long-Term Assets
206.81M 224.88M 30.48M 69.58M
Total Assets
587.28M 725.79M 630.24M 452.49M
Account Payables
12.25M 7.4M 8.01M 3.43M
Deferred Revenue
n/a 4.14M 3.31M n/a
Short-Term Debt
1.73M n/a 483K 1.16M
Other Current Liabilities
86.01M 26.05M 19.62M 12.13M
Total Current Liabilities
99.99M 78.17M 51.05M 29.97M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
6.18M 21.4M 21M 129K
Total Liabilities
106.17M 99.57M 72.05M 30.1M
Total Debt
7.91M 7.06M 5.25M 1.29M
Common Stock
7K 7K 6K 5K
Retained Earnings
-1.15B -895.03M -569.93M -292.51M
Comprehensive Income
304K 1.19M -767K -312K
Shareholders Equity
481.1M 626.22M -569.93M 422.4M
Total Investments
396.36M 488.49M 529.52M 331.65M